Essity has entered into an agreement to acquire Edgewell Personal Care‘s feminine care business for $340 million. The acquisition includes the brands Carefree, Stayfree, and o.b. in North America and Playtex globally.
The asset deal includes the brands in the United States, Canada, and the Caribbean, global feminine care rights for the Playtex brand, and a production facility in Dover, Delaware. The business offers liners, pads, and tampons.
“I´m looking forward to further grow these well-known brands, using our established recipe for success within Feminine Care,” said Ulrika Kolsrud, President and CEO of Essity. “With this acquisition we are building a stronger personal care business in North America, in line with our strategy to focus on high yielding categories in attractive geographies.”
For the 12 months ending June 30, 2025, the business reported net sales of $261 million with a segment operating profit of $17 million. The business has approximately 500 employees, with approximately 450 based at the Dover production facility.
The purchase price represents an EBITDA multiple of approximately 12.1x on a pro-forma IFRS basis, and 8.3x including estimated run-rate synergies on a pro-forma basis.
The transaction is subject to regulatory approvals and is expected to close in the first quarter of 2026.
Essity’s existing feminine care portfolio includes regional brands such as Libresse, Bodyform, Nana, Saba, Libra, and Nosotras, offering pads, liners, tampons, intimate soaps, intimate wipes, leakproof apparel, and menstrual cups.
